Sahajanand Medical IPO
ListedSahajanand Medical · BSE, NSE · Mainboard IPO
Sahajanand Medical IPO listed on 23 Oct 2026 after being issued at ₹327–344 per share. Latest GMP is ₹18 (+5.2%). Overall subscription stands at 14.2x. Lot size is 43 shares.
Price band
₹327–344
GMP (unofficial)
₹18
+5.2%
Subscription
14.2x
Min. investment
₹14,792
43 shares / lot
Sahajanand Medical IPO details
| Price band | ₹327–344 per share |
|---|---|
| Lot size | 43 shares |
| Minimum investment (retail) | ₹14,792 (1 lot at ₹344) |
| Maximum retail application | 13 lots (₹1,92,296) |
| Issue size | ₹475.5 crore |
| IPO open date | 15 Oct 2026 |
| IPO close date | 19 Oct 2026 |
| Basis of allotment | 21 Oct 2026 |
| Refunds / UPI unblock | 22 Oct 2026 |
| Listing date | 23 Oct 2026 |
| Listing exchanges | BSE, NSE |
Sahajanand Medical IPO GMP today
Grey market premium: ₹18(+5.2%)· expected listing price ≈ ₹362
As of 23 Oct, 11:49 am IST · source ipowatch.in · unofficial, not exchange-sanctioned · indicative and may be inaccurate.
| Date | GMP |
|---|---|
| 23 Oct 2026 | ₹18 |
| 22 Oct 2026 | ₹15 |
| 21 Oct 2026 | ₹24 |
| 20 Oct 2026 | ₹25 |
| 19 Oct 2026 | ₹25 |
| 18 Oct 2026 | ₹15 |
| 17 Oct 2026 | ₹15 |
Sahajanand Medical IPO subscription status
as of 20 Oct, 12:55 am IST| Category | Times subscribed |
|---|---|
| QIB (Qualified Institutional Buyers) | 34.7x |
| bNII (Big HNI, above ₹10 lakh) | 16.4x |
| sNII (Small HNI, ₹2–10 lakh) | 11.2x |
| Retail (RII) | 3.04x |
| Employee | 0.37x |
| Total | 14.2x |
Source: ipowatch.in, chittorgarh.com · bNII = bids above ₹10 lakh, sNII = ₹2–10 lakh.
Sahajanand Medical IPO review — broker & analyst views
1 house tracked: 0 positive · 0 cautious · 1 neutral · 0 negative
| House | Rating | Note |
|---|---|---|
| Capital Market | Neutral | chittorgarh ↗ |
Ratings as published by each house; links open the source. IPOSarthi does not rate IPOs.
Sahajanand Medical IPO news
- IPO Listings Today: Tonbo vs Zetwerk vs Bonfiglioli vs Sahajanand
Univest · 23 Oct, 9:06 pm
- Sahajanand Medical Technologies IPO DRHP: ₹1,210.50 crore revenue; ~25% India DES market share
scanx.trade · 23 Oct, 4:28 pm
- Sahajanand Med Tech IPO Reaches A High Of Rs 409
https://www.fintechbiznews.com/ · 23 Oct, 4:28 pm
- Sahajanand Medical Technologies IPO Listing
IPO Watch · 23 Oct, 1:52 pm
- Sahajanand Medical IPO GMP Today with Listing Gain Expectation
IPO Watch · 23 Oct, 1:49 pm
Sahajanand Medical IPO — frequently asked questions
- What is the GMP of Sahajanand Medical IPO today?
- As of 23 Oct, 11:49 am IST, the grey market premium (GMP) of Sahajanand Medical IPO is ₹18 per share, about +5.2% over the upper price band of ₹344, which points to an indicative listing price near ₹362. GMP is an unofficial, off-exchange figure sourced from public trackers (ipowatch.in); it can change quickly and does not guarantee the listing price.
- What is the lot size and minimum investment for Sahajanand Medical IPO?
- One lot of Sahajanand Medical IPO is 43 shares. At the upper price band of ₹344, one lot costs ₹14,792, which is the minimum retail application. Retail investors can bid for up to 13 lots (₹1,92,296) within the ₹2 lakh retail cap. Small HNI (sNII) applications start at 14 lots (₹2,07,088) and big HNI (bNII) applications at 68 lots (₹10,05,856).
- When is the Sahajanand Medical IPO allotment and listing date?
- Sahajanand Medical IPO opened on 15 Oct 2026 and closed on 19 Oct 2026. The basis of allotment is expected on 21 Oct 2026, refunds / UPI unblocking on 22 Oct 2026, and the shares are expected to list on 23 Oct 2026 on BSE and NSE.
- How many times is Sahajanand Medical IPO subscribed?
- As of 20 Oct, 12:55 am IST, Sahajanand Medical IPO is subscribed 14.2x overall — QIB 34.7x, bNII 16.4x, sNII 11.2x, Retail 3.04x, Employee 0.37x. Figures come from exchange bid data via public trackers and update through the bidding window.
- Should I apply for Sahajanand Medical IPO?
- IPOSarthi does not make recommendations — this page only lays out the data. The grey market is currently pricing the issue at ₹18 above the upper band (+5.2%). The book is 14.2x subscribed overall. 1 broker house has published a view: 0 positive, 0 cautious, 1 neutral, 0 negative. Read the red herring prospectus, weigh the company's financials and valuation against your own goals and risk appetite, and consult a SEBI-registered investment adviser before applying. GMP and subscription are indicative, not a forecast of listing gains.
Planning to apply?
Add Sahajanand Medical to your fund plan and see how much cash to keep ready in each account — free.
Other current IPOs
GMP and prices shown are indicative, sourced from public trackers, and may be inaccurate — this is a hobby project, not investment advice. See Disclaimer.